These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26696395)

  • 41. Antibody-dependent cellular cytotoxicity in HIV infections.
    Ahmad A; Menezes J
    FASEB J; 1996 Feb; 10(2):258-66. PubMed ID: 8641559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele.
    Jochems C; Hodge JW; Fantini M; Fujii R; Morillon YM; Greiner JW; Padget MR; Tritsch SR; Tsang KY; Campbell KS; Klingemann H; Boissel L; Rabizadeh S; Soon-Shiong P; Schlom J
    Oncotarget; 2016 Dec; 7(52):86359-86373. PubMed ID: 27861156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity.
    Lichtfuss GF; Meehan AC; Cheng WJ; Cameron PU; Lewin SR; Crowe SM; Jaworowski A
    J Leukoc Biol; 2011 Jan; 89(1):149-58. PubMed ID: 20884651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-HIV antibody-dependent activation of NK cells impairs NKp46 expression.
    Parsons MS; Tang CC; Jegaskanda S; Center RJ; Brooks AG; Stratov I; Kent SJ
    J Immunol; 2014 Jan; 192(1):308-15. PubMed ID: 24319263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.
    Madhavi V; Wines BD; Amin J; Emery S; ; Lopez E; Kelleher A; ; Center RJ; Hogarth PM; Chung AW; Kent SJ; Stratov I
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28701393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC.
    Worley MJ; Fei K; Lopez-Denman AJ; Kelleher AD; Kent SJ; Chung AW
    J Immunol Methods; 2018 Jun; 457():41-52. PubMed ID: 29605231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brief Report: The Anti-HIV-1 ADCC-Mediating Antibodies From Cervicovaginal Secretions of HIV-Infected Women Have an Ability to Mediate Lysing of Autologous CD4+ HIV-Infected Cells.
    Dhande J; Angadi M; Murugavel KG; Poongulali S; Nandagopal P; Vignesh R; Ghate M; Kulkarni S; Thakar M
    J Acquir Immune Defic Syndr; 2018 Oct; 79(2):277-282. PubMed ID: 30211779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.
    Isitman G; Tremblay-McLean A; Lisovsky I; Bruneau J; Lebouché B; Routy JP; Bernard NF
    PLoS One; 2016; 11(10):e0164517. PubMed ID: 27732638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
    Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
    J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contribution of NK Cell Education to both Direct and Anti-HIV-1 Antibody-Dependent NK Cell Functions.
    Kristensen AB; Kent SJ; Parsons MS
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FcγRIIIa receptor polymorphism influences NK cell mediated ADCC activity against HIV.
    Talathi SP; Shaikh NN; Pandey SS; Saxena VA; Mamulwar MS; Thakar MR
    BMC Infect Dis; 2019 Dec; 19(1):1053. PubMed ID: 31842762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of NK cells by ADCC antibodies and HIV disease progression.
    Chung AW; Navis M; Isitman G; Wren L; Silvers J; Amin J; Kent SJ; Stratov I
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):127-31. PubMed ID: 21792067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Env-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular Cytotoxicity.
    Ruiz MJ; Ghiglione Y; Falivene J; Laufer N; Holgado MP; Socías ME; Cahn P; Sued O; Giavedoni L; Salomón H; Gherardi MM; Rodríguez AM; Turk G
    J Virol; 2016 Jan; 90(2):670-81. PubMed ID: 26491172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. gp120-directed antibody-dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV-1 disease.
    Skowron G; Cole BF; Zheng D; Accetta G; Yen-Lieberman B
    AIDS; 1997 Dec; 11(15):1807-14. PubMed ID: 9412698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brief Report: Seminal Plasma Anti-HIV Antibodies Trigger Antibody-dependent Cellular Cytotoxicity: Implications for HIV Transmission.
    Parsons MS; Madhavi V; Ana-Sosa-Batiz F; Center RJ; Wilson KM; Bunupuradah T; Ruxrungtham K; Kent SJ
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):17-23. PubMed ID: 26761269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obstacles to ideal anti-HIV antibody-dependent cellular cytotoxicity responses.
    Wren LH; Stratov I; Kent SJ; Parsons MS
    Vaccine; 2013 Nov; 31(47):5506-17. PubMed ID: 23981432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children.
    Kumar S; Batra H; Singh S; Chawla H; Singh R; Katpara S; Hussain AW; Das BK; Lodha R; Kabra SK; Luthra K
    J Gen Virol; 2020 Dec; 101(12):1289-1299. PubMed ID: 32915123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measurement of direct and indirect forms of anti-HIV-1 ADCC: implications for other retroviral disease.
    Weinhold KJ; Tyler DS; Lyerly HK
    Dev Biol Stand; 1990; 72():343-8. PubMed ID: 2282991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity.
    Klein JS; Webster A; Gnanapragasam PN; Galimidi RP; Bjorkman PJ
    AIDS; 2010 Jul; 24(11):1633-40. PubMed ID: 20597163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.